1. Morbid obesity in women is associated to a lower prevalence of thyroid nodules.
Cappelli C, Pirola I, Mittempergher F, De Martino E, Casella C, Agosti B, Nascimbeni R, Formenti A, Rosei EA, Castellano M.
Obes Surg. 2012 Mar;22(3):460-4.

2. Thyreotropin levels in diabetic patients on metformin treatment.
Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti A, Zarra E, Valentini U, Leporati P, Chiovato L, Castellano M.
Eur J Endocrinol. 2012 Aug;167(2):261-5

3. Real-time elastography: a useful tool for predicting malignancy in thyroid nodules with nondiagnostic cytologic findings.
Cappelli C, Pirola I, Gandossi E, Agosti B, Cimino E, Casella C, Formenti A, Castellano M.
J Ultrasound Med. 2012 Nov;31(11):1777-82.

4. Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery.
Pirola I, Formenti AM, Gandossi E, Mittempergher F, Casella C, Agosti B, Cappelli C.
Obes Surg. 2013 Sep;23(9):1493-6

5. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C, Pirola I, Gandossi E, Formenti A, Castellano M.
Eur J Endocrinol. 2013 Nov 22;170(1):95-9

6. Ultrasound findings of subacute thyroiditis: a single institution retrospective review.
Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M.
Acta Radiol. 2014 May;55(4):429-33.

7. Metformin-induced thyrotropin suppression is not associated with cardiac effects.
Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti AM, De Cata P, Salvetti M, Chiovato L, Castellano M.
Hormones (Athens). 2014 Apr-Jun;13(2):252-8.

8. Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube.
Pirola I, Daffini L, Gandossi E, Lombardi D, Formenti A, Castellano M, Cappelli C.
J Endocrinol Invest. 2014 Jun;37(6):583-7

9. Elastography Evaluation of Benign Thyroid Nodules in Patients Affected by Hashimoto’s Thyroiditis.
Cappelli C, Pirola I, Gandossi E, Formenti A, Agosti B, Castellano M.
Int J Endocrinol. 2015;2015:367054

10. Liquid levothyroxine and its potential use.
Formenti AM, Daffini L, Pirola I, Gandossi E, Cristiano A, Cappelli C.
Hormones (Athens). 2015 Apr-Jun;14(2):183-9

11. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
Cappelli C, Pirola I, Daffini L, Formenti A, Iacobello C, Cristiano A, Gandossi E, Agabiti Rosei E, Castellano M.
Thyroid. 2016 Feb;26(2):197-202.

12. Treatment of hypothyroidism: all that glitters is gold?
Formenti AM, Mazziotti G, Giubbini R, Giustina A.
Endocrine. 2016 Jun;52(3):411-3.

13. Skeletal Fragility in Endogenous Hypercortisolism.
Mazziotti G, Delgado A, Maffezzoni F, Formenti A, Giustina A.
Front Horm Res. 2016;46:66-73.

14. Current and future medical treatments for patients with acromegaly.
Maffezzoni F, Formenti AM, Mazziotti G, Frara S, Giustina A.
Expert Opin Pharmacother. 2016 Jun 17:1631-42.

15. Growth hormone receptor isoforms and fracture risk in adult-onset growth hormonedeficient patients
Mormando M, Chiloiro S, Bianchi A, Giampietro A, Angelini F, Tartaglione L, Nasto L, Milardi D, Formenti AM, Giustina A, De Marinis L
Clin Endocrinol 2016 Nov; 85: 717-724.

16. Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-1 and PTH/VITAMIN D axes, treatment options and guidelines.
Mazziotti G, Formenti AM, Adler RA, Bilezikian JP, Grossman A, Sbardella E, Minisola S, Giustina A
Endocrine 2016 Dec; 54: 603-611.

17. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
Pedersini R, Monteverdi S, Mazziotti G, Amoroso V, Roca E, Maffezzoni F, Vassalli L, Rodella F, Formenti AM, Frara S, Maroldi R, Berruti A, Simoncini E, Giustina A.
Bone. 2017 Apr;97:147-152.

18. Diabetes in Cushing Disease.
Mazziotti G, Formenti AM, Frara S, Maffezzoni F, Doga M, Giustina A.
Curr Diab Rep. 2017 May;17:32. Review.

19. High-dose and high-frequency lanreotide autogel in acromegaly: a randomized, multicenter study.
Giustina A, Mazziotti G, Cannavò S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2454-2464. doi: 10.1210/jc.2017-00142.

20. Growth hormone deficiency in treated acromegaly and active Cushing’s syndrome.
Formenti AM, Maffezzoni F, Doga M, Mazziotti G, Giustina A
Best Pract Res Clin Endocrinol Metab 2017; 31:79-90.

21. Management of endocrine disease: risk of overtreatment of patients with adrenal insufficiency: current and emerging aspects.
Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, Giustina A.
Eur J Endocrinol. 2017 Nov;177(5):R231-R248. doi: 10.1530/EJE-17-0154. Epub 2017 Jun 5. Review.

22. Prevalence of morphometric vertebral fractures in “difficult” patients with acromegaly with different biochemical outcomes after multimodal treatment
Chiloiro S, Mormando M, Bianchi A, Giampietro A, Milardi D, Bima C, Grande G, Formenti AM, Mazziotti G, Pontecorvi A, Giustina A, De Marinis L.
Endocrine. 2018 Feb;59(2):449-453. doi: 10.1007/s12020-017-1391-5. Epub 2017 Aug

23. Acromegaly and bone.
Maffezzoni F. et Formenti AM
Minerva Endocrinol. 2018 Jun;43(2):168-182. doi:10.23736/S0391-1977.17.02733-X. Epub 2017 Sep 7.

24. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.
Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.
Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2.

25. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R.
Endocrine. 2018 Jan;59(1):90-101. doi: 10.1007/s12020-017-1455-6. Epub 2017 Nov 6.

26. High prevalence of radiological vertebral fractures in women on TSH-suppressive therapy for thyroid carcinoma
Mazziotti G, Formenti AM, Frara S, Olivetti R, Banfi G, Memo M, Maroldi R, Giubbini R, Giustina A.
J Clin Endocrinol Metab. 2018 Mar 1;103(3):956-964. doi: 10.1210/jc.2017-01986.

27. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R.
Eur J Endocrinol. 2018 Sep;179(3):143-151. doi: 10.1530/EJE-18-0253. Epub 2018 Jun 13